A 58 year male diabetic, hypertensive and smoker presented for executive checkup in cardiology clinic

A 58 year male diabetic, hypertensive and smoker presented for executive checkup in cardiology clinic. He is asymptomatic except for feeling fatigue enough to walk >200 m. His physical examination was normal. You ordered baseline tests including lipid profile. All labs are normal except for elevated cholesterol and LDL. His ECG was normal. Please answer following questions based on guidelines

a. When should we expect PAD?

b. You screened with ABI and it turn out to be 1.29. Will you stop evaluating him or proceed for another test

c. How would you differentiate pseudoclaudication from arterial claudication?

d. How would you classify this patient based on fontaine classification

Answers:

a.      1)All patients above 70 years of age , 2) Between 50-70years with additional factors like DM, Smoking, 3)Any age with symptom of claudication, Ischemic Ulcer/gangrene

b.      No (may be due to incompressible Vessel), Exercise ABI, Toe Brachial Index

c.       Exercise ABI (In true arterial claudication ABI will decrease <0.9 whereas in pseudoclaudication it will remain normal/borderline). Normal= 1.0 to 1.4, Borderline 0.91 to 0.99

d.      Class IIa (Pain free claudication distance >200m)

References:

2013 practice guidelines (Compilation of 2005 and 2011 ACCF/ AHA guidelines) for management of PAD
Braunwald Heart Disease – A Textbook of Cardiovascular Medicine 10^th edition - Chapter 58 – Page 1316

Comments

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚

𝘼𝙣𝙩𝙞𝙘𝙤𝙖𝙜𝙪𝙡𝙖𝙩𝙞𝙤𝙣 𝘼𝙛𝙩𝙚𝙧 𝙎𝙩𝙧𝙤𝙠𝙚 in Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts. The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Dr. Usman's Cardiology Notes

Search This Blog